| Product Code: ETC13269653 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America Fungal Infections Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Fungal Infections Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Fungal Infections Market Revenues & Volume, 2021 & 2031F |
3.3 North America Fungal Infections Market - Industry Life Cycle |
3.4 North America Fungal Infections Market - Porter's Five Forces |
3.5 North America Fungal Infections Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Fungal Infections Market Revenues & Volume Share, By Types, 2021 & 2031F |
3.7 North America Fungal Infections Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.8 North America Fungal Infections Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.9 North America Fungal Infections Market Revenues & Volume Share, By Dosage Form, 2021 & 2031F |
3.10 North America Fungal Infections Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.11 North America Fungal Infections Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.12 North America Fungal Infections Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 North America Fungal Infections Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Fungal Infections Market Trends |
6 North America Fungal Infections Market, 2021 - 2031 |
6.1 North America Fungal Infections Market, Revenues & Volume, By Types, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America Fungal Infections Market, Revenues & Volume, By Aspergillosis, 2021 - 2031 |
6.1.3 North America Fungal Infections Market, Revenues & Volume, By Blastomycosis, 2021 - 2031 |
6.1.4 North America Fungal Infections Market, Revenues & Volume, By Candidiasis, 2021 - 2031 |
6.1.5 North America Fungal Infections Market, Revenues & Volume, By Candida auris, 2021 - 2031 |
6.1.6 North America Fungal Infections Market, Revenues & Volume, By Coccidioidomycosis, 2021 - 2031 |
6.1.7 North America Fungal Infections Market, Revenues & Volume, By Cryptococcus gattii infection, 2021 - 2031 |
6.1.8 North America Fungal Infections Market, Revenues & Volume, By Fungal Eyes Infection, 2021 - 2031 |
6.2 North America Fungal Infections Market, Revenues & Volume, By Drugs, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America Fungal Infections Market, Revenues & Volume, By Corticosteroids, 2021 - 2031 |
6.2.3 North America Fungal Infections Market, Revenues & Volume, By Corticosteroid-Sparing Agents, 2021 - 2031 |
6.2.4 North America Fungal Infections Market, Revenues & Volume, By Immunosuppressive, 2021 - 2031 |
6.2.5 North America Fungal Infections Market, Revenues & Volume, By Immunomodulator, 2021 - 2031 |
6.2.6 North America Fungal Infections Market, Revenues & Volume, By Antifungals, 2021 - 2031 |
6.2.7 North America Fungal Infections Market, Revenues & Volume, By Others, 2021 - 2031 |
6.3 North America Fungal Infections Market, Revenues & Volume, By Treatment, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America Fungal Infections Market, Revenues & Volume, By Antifungal, 2021 - 2031 |
6.3.3 North America Fungal Infections Market, Revenues & Volume, By Others, 2021 - 2031 |
6.4 North America Fungal Infections Market, Revenues & Volume, By Dosage Form, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 North America Fungal Infections Market, Revenues & Volume, By Creams, 2021 - 2031 |
6.4.3 North America Fungal Infections Market, Revenues & Volume, By Gels, 2021 - 2031 |
6.4.4 North America Fungal Infections Market, Revenues & Volume, By Ointment, 2021 - 2031 |
6.4.5 North America Fungal Infections Market, Revenues & Volume, By Solution, 2021 - 2031 |
6.4.6 North America Fungal Infections Market, Revenues & Volume, By Lotions, 2021 - 2031 |
6.4.7 North America Fungal Infections Market, Revenues & Volume, By Others, 2021 - 2031 |
6.5 North America Fungal Infections Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 North America Fungal Infections Market, Revenues & Volume, By Oral, 2021 - 2031 |
6.5.3 North America Fungal Infections Market, Revenues & Volume, By Parenteral, 2021 - 2031 |
6.5.4 North America Fungal Infections Market, Revenues & Volume, By Topical, 2021 - 2031 |
6.5.5 North America Fungal Infections Market, Revenues & Volume, By Vaginal, 2021 - 2031 |
6.5.6 North America Fungal Infections Market, Revenues & Volume, By Others, 2021 - 2031 |
6.6 North America Fungal Infections Market, Revenues & Volume, By End-Users, 2021 - 2031 |
6.6.1 Overview & Analysis |
6.6.2 North America Fungal Infections Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.6.3 North America Fungal Infections Market, Revenues & Volume, By Homecare, 2021 - 2031 |
6.6.4 North America Fungal Infections Market, Revenues & Volume, By Specialty Clinics, 2021 - 2031 |
6.6.5 North America Fungal Infections Market, Revenues & Volume, By Others, 2021 - 2031 |
6.7 North America Fungal Infections Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
6.7.1 Overview & Analysis |
6.7.2 North America Fungal Infections Market, Revenues & Volume, By Hospital Pharmacy, 2021 - 2031 |
6.7.3 North America Fungal Infections Market, Revenues & Volume, By Retail Pharmacy, 2021 - 2031 |
6.7.4 North America Fungal Infections Market, Revenues & Volume, By Online Pharmacies, 2021 - 2031 |
6.7.5 North America Fungal Infections Market, Revenues & Volume, By Others, 2021 - 2031 |
7 North America Fungal Infections Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America Fungal Infections Market, Revenues & Volume, By Types, 2021 - 2031 |
7.2.1 United States (US) Fungal Infections Market, Revenues & Volume, By Types, 2021 - 2031 |
7.2.2 Canada Fungal Infections Market, Revenues & Volume, By Types, 2021 - 2031 |
7.2.3 Rest of North America Fungal Infections Market, Revenues & Volume, By Types, 2021 - 2031 |
7.3 North America Fungal Infections Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
7.3.1 United States (US) Fungal Infections Market, Revenues & Volume, By Drugs, 2021 - 2031 |
7.3.2 Canada Fungal Infections Market, Revenues & Volume, By Drugs, 2021 - 2031 |
7.3.3 Rest of North America Fungal Infections Market, Revenues & Volume, By Drugs, 2021 - 2031 |
7.4 North America Fungal Infections Market, Revenues & Volume, By Treatment, 2021 - 2031 |
7.4.1 United States (US) Fungal Infections Market, Revenues & Volume, By Treatment, 2021 - 2031 |
7.4.2 Canada Fungal Infections Market, Revenues & Volume, By Treatment, 2021 - 2031 |
7.4.3 Rest of North America Fungal Infections Market, Revenues & Volume, By Treatment, 2021 - 2031 |
7.5 North America Fungal Infections Market, Revenues & Volume, By Dosage Form, 2021 - 2031 |
7.5.1 United States (US) Fungal Infections Market, Revenues & Volume, By Dosage Form, 2021 - 2031 |
7.5.2 Canada Fungal Infections Market, Revenues & Volume, By Dosage Form, 2021 - 2031 |
7.5.3 Rest of North America Fungal Infections Market, Revenues & Volume, By Dosage Form, 2021 - 2031 |
7.6 North America Fungal Infections Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.6.1 United States (US) Fungal Infections Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.6.2 Canada Fungal Infections Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.6.3 Rest of North America Fungal Infections Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.7 North America Fungal Infections Market, Revenues & Volume, By End-Users, 2021 - 2031 |
7.7.1 United States (US) Fungal Infections Market, Revenues & Volume, By End-Users, 2021 - 2031 |
7.7.2 Canada Fungal Infections Market, Revenues & Volume, By End-Users, 2021 - 2031 |
7.7.3 Rest of North America Fungal Infections Market, Revenues & Volume, By End-Users, 2021 - 2031 |
7.8 North America Fungal Infections Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.8.1 United States (US) Fungal Infections Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.8.2 Canada Fungal Infections Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.8.3 Rest of North America Fungal Infections Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
8 North America Fungal Infections Market Key Performance Indicators |
9 North America Fungal Infections Market - Export/Import By Countries Assessment |
10 North America Fungal Infections Market - Opportunity Assessment |
10.1 North America Fungal Infections Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Fungal Infections Market Opportunity Assessment, By Types, 2021 & 2031F |
10.3 North America Fungal Infections Market Opportunity Assessment, By Drugs, 2021 & 2031F |
10.4 North America Fungal Infections Market Opportunity Assessment, By Treatment, 2021 & 2031F |
10.5 North America Fungal Infections Market Opportunity Assessment, By Dosage Form, 2021 & 2031F |
10.6 North America Fungal Infections Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
10.7 North America Fungal Infections Market Opportunity Assessment, By End-Users, 2021 & 2031F |
10.8 North America Fungal Infections Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
11 North America Fungal Infections Market - Competitive Landscape |
11.1 North America Fungal Infections Market Revenue Share, By Companies, 2022 |
11.2 North America Fungal Infections Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here